Masimo, a Danaher (NYSE:DHR) company, announced that it appointed Tim Benner as its president, effective Aug. 3, 2026. Benner’s appointment comes at the same time as Danaher’s naming of Julie Sawyer Montgomery as its new president and CEO. Sawyer Montgomery oversaw Danaher’s $10 billion acquisition of Masimo and led the unit in its early days as […]
Danaher Corp.
Danaher promotes new CEO from within
Danaher (NYSE:DHR) announced today that it appointed Julie Sawyer Montgomery as its new president and CEO. Sawyer Montgomery’s appointment goes into effect on Oct. 1, 2026. On that date, Rainer Blair intends to retire, serving as a senior advisor until March 31, 2027, to ensure a seamless transition. Since she joined the company in 2017, […]
Masimo gets FDA clearance for pediatric patient state index platform
Danaher’s (NYSE:DHR) Masimo unit announced today that it received FDA 510(k) clearance for its Patient State Index (PSi) for pediatric patients. Irvine, California-based Masimo — which became a part of Danaher through a $10 billion acquisition last month — said the PSi represents the first-and-only sedation score specifically designed for the unique physiology of the pediatric […]
Masimo gets FDA nod for AI-enabled opioid-induced respiratory depression detection tech
Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform. Irvine, California-based Masimo — which became a part of Danaher through a $10 billion acquisition earlier this month — designed the capability for its Radius VSM wearable continuous patient monitor. Enabled by the next-generation smartSET pulse oximetry sensor […]
Danaher completes $10B acquisition of Masimo
Danaher (NYSE:DHR) announced today that it completed its previously announced acquisition of Masimo (Nasdaq:MASI). In February, the companies announced an agreement that would see Danaher acquire the Irvine, California-based health monitoring technology company for $180 per share, amounting to approximately $9.9 billion. Masimo shareholders approved the acquisition last month. Today, Danaher said it completed the […]
Masimo shareholders give green light to $10B acquisition by Danaher
Masimo (Nasdaq:MASI) announced today that its shareholders voted in favor of the proposed acquisition of the company by Danaher (NYSE:DHR). In February, Danaher and Masimo announced an agreement that would see the former acquire the health monitoring technology company for $180 per share, amounting to approximately $9.9 billion. Washington, D.C.–based Danaher operates across life sciences […]
Danaher to buy Masimo for $10B
Danaher announced that it agreed to acquire Masimo in a deal worth approximately $9.9 billion. The Financial Times first reported that the companies were close to a deal on Monday, Feb. 16. Both companies confirmed an agreement today. The deal’s value marks a nearly $3 billion premium to Masimo’s closing value last Friday, Feb. 13. […]
Danaher names new chief technology and AI officer, EVP for Life Sciences
Danaher announced today that it appointed a new chief technology and AI officer and a new EVP to lead Life Sciences. The company chose Martin Stumpe to take on the role of chief technology and AI officer, effective Oct. 1, 2025. It selected Greg Milosevich to become EVP with responsibility for Life Sciences, effective July […]
Danaher beats The Street in Q3
Danaher (NYSE:DHR) shares dipped today despite third-quarter results that came in well ahead of the consensus forecast. The Washington, D.C.-based company posted profits of $1.6 billion, or $2.10 per share, on sales of $7.7 billion for the three months ended Sept. 30, 2022, for a 35.8% bottom-line gain on sales growth of 6%. Adjusted to […]
Danaher rises on Street-beating Q2
Danaher (NYSE:DHR) shares got a boost today on second-quarter results that came in well ahead of the consensus forecast. Shares of DHR were up 7.7% at $275.61 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.3%. The Washington, D.C.-based […]
Danaher beats The Street in Q1
Danaher (NYSE:DHR) shares dipped slightly today on first-quarter results that came in ahead of the consensus forecast. The Washington, D.C.-based company posted profits of $1.7 billion, or $2.31 per share, on sales of $7.7 billion for the three months ended April 1, 2022, for a 1.3% bottom-line gain on sales growth of 12.1%. Adjusted to […]
